Stockreport

Anchiano bails on bladder cancer gene therapy; shares down 33% premarket [Seeking Alpha]

Anchiano Therapeutics Ltd. - American Depositary Shares  (ANCN) 
PDF Anchiano bails on bladder cancer gene therapy; shares down 33% premarket Ultra-thinly traded nano cap Anchiano Therapeutics (NASDAQ: ANCN 33% terminate Codex The company [Read more]